Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Scaffolded Antigens in Yeast Cell Particle Vaccines Provide Protection against Systemic Polyoma Virus Infection.

Tipper DJ, Szomolanyi-Tsuda E.

J Immunol Res. 2016;2016:2743292. doi: 10.1155/2016/2743292. Epub 2016 Apr 26.

2.

NK cells and virus-related cancers.

Mishra R, Welsh R, Szomolanyi-Tsuda E.

Crit Rev Oncog. 2014;19(1-2):107-19. Review.

3.

Long-lasting T cell-independent IgG responses require MyD88-mediated pathways and are maintained by high levels of virus persistence.

Raval FM, Mishra R, Garcea RL, Welsh RM, Szomolanyi-Tsuda E.

MBio. 2013 Nov 5;4(6):e00812-13. doi: 10.1128/mBio.00812-13.

4.

Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.

Mishra R, Polic B, Welsh RM, Szomolanyi-Tsuda E.

J Immunol. 2013 Jul 15;191(2):961-70. doi: 10.4049/jimmunol.1203328. Epub 2013 Jun 14.

5.

Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response.

Fang CM, Roy S, Nielsen E, Paul M, Maul R, Paun A, Koentgen F, Raval FM, Szomolanyi-Tsuda E, Pitha PM.

Genes Immun. 2012 Jul;13(5):421-30. doi: 10.1038/gene.2012.10. Epub 2012 Apr 26.

6.

Virion assembly factories in the nucleus of polyomavirus-infected cells.

Erickson KD, Bouchet-Marquis C, Heiser K, Szomolanyi-Tsuda E, Mishra R, Lamothe B, Hoenger A, Garcea RL.

PLoS Pathog. 2012;8(4):e1002630. doi: 10.1371/journal.ppat.1002630. Epub 2012 Apr 5.

7.

Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.

Wigglesworth KM, Racki WJ, Mishra R, Szomolanyi-Tsuda E, Greiner DL, Galili U.

J Immunol. 2011 Apr 1;186(7):4422-32. doi: 10.4049/jimmunol.1002324. Epub 2011 Feb 25.

8.

NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.

Mishra R, Chen AT, Welsh RM, Szomolanyi-Tsuda E.

PLoS Pathog. 2010 May 27;6(5):e1000924. doi: 10.1371/journal.ppat.1000924.

9.

p53 represses class switch recombination to IgG2a through its antioxidant function.

Guikema JE, Schrader CE, Brodsky MH, Linehan EK, Richards A, El Falaky N, Li DH, Sluss HK, Szomolanyi-Tsuda E, Stavnezer J.

J Immunol. 2010 Jun 1;184(11):6177-87. doi: 10.4049/jimmunol.0904085. Epub 2010 May 5. Erratum in: J Immunol. 2011 Nov 1;187(9):4920.

10.

The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, Hornung V, Vogel SN, Szomolanyi-Tsuda E, Fitzgerald KA.

Nat Immunol. 2010 May;11(5):395-402. doi: 10.1038/ni.1864. Epub 2010 Mar 28.

11.

Generation of protective T cell-independent antiviral antibody responses in SCID mice reconstituted with follicular or marginal zone B cells.

Guay HM, Mishra R, Garcea RL, Welsh RM, Szomolanyi-Tsuda E.

J Immunol. 2009 Jul 1;183(1):518-23. doi: 10.4049/jimmunol.0900068.

12.

Immunity to polyomavirus infection: the polyomavirus-mouse model.

Swanson PA 2nd, Lukacher AE, Szomolanyi-Tsuda E.

Semin Cancer Biol. 2009 Aug;19(4):244-51. doi: 10.1016/j.semcancer.2009.02.003. Epub 2009 Feb 14. Review.

13.

Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Kemball CC, Szomolanyi-Tsuda E, Lukacher AE.

J Virol. 2007 Dec;81(24):13743-53. Epub 2007 Oct 3.

14.

The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection.

Kemball CC, Pack CD, Guay HM, Li ZN, Steinhauer DA, Szomolanyi-Tsuda E, Lukacher AE.

J Immunol. 2007 Jul 15;179(2):1113-21.

15.

MyD88 is required for the formation of long-term humoral immunity to virus infection.

Guay HM, Andreyeva TA, Garcea RL, Welsh RM, Szomolanyi-Tsuda E.

J Immunol. 2007 Apr 15;178(8):5124-31.

16.

Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen.

Jellison ER, Guay HM, Szomolanyi-Tsuda E, Welsh RM.

Eur J Immunol. 2007 Jan;37(1):119-28.

17.

T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice.

Szomolanyi-Tsuda E, Seedhom MO, Carroll MC, Garcea RL.

Virology. 2006 Aug 15;352(1):52-60. Epub 2006 Jun 2.

18.

Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo.

Szomolanyi-Tsuda E, Liang X, Welsh RM, Kurt-Jones EA, Finberg RW.

J Virol. 2006 May;80(9):4286-91.

19.

Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.

Kemball CC, Lee ED, Szomolanyi-Tsuda E, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2006 Feb 1;176(3):1814-24.

20.

Judging a virus by its cover.

Szomolanyi-Tsuda E, Welsh RM.

J Clin Invest. 2004 Oct;114(7):895-7.

21.

Mycoplasma infection induces a scleroderma-like centrosome autoantibody response in mice.

Gavanescu I, Pihan G, Halilovic E, Szomolanyi-Tsuda E, Welsh RM, Doxsey S.

Clin Exp Immunol. 2004 Aug;137(2):288-97.

22.

Immunological memory to viral infections.

Welsh RM, Selin LK, Szomolanyi-Tsuda E.

Annu Rev Immunol. 2004;22:711-43. Review.

PMID:
15032594
23.

The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes.

Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM.

J Immunol. 2003 Apr 1;170(7):3819-27.

24.

B cell memory: sapping the T cell.

Welsh RM, Stepp SE, Szomolanyi-Tsuda E.

Nat Med. 2003 Feb;9(2):164-6. No abstract available.

PMID:
12563333
25.

Tumor viral escape from inhibited T cells.

Welsh RM, Stepp SE, Szomolanyi-Tsuda E, Peacock CD.

Nat Immunol. 2002 Feb;3(2):112-4. No abstract available.

PMID:
11812984
26.

Plasma cell differentiation requires the transcription factor XBP-1.

Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH.

Nature. 2001 Jul 19;412(6844):300-7.

PMID:
11460154
27.

Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.

Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, Welsh RM.

J Immunol. 2001 Jun 1;166(11):6784-94.

28.

Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.

Szomolanyi-Tsuda E, Brien JD, Dorgan JE, Garcea RL, Woodland RT, Welsh RM.

Virology. 2001 Feb 15;280(2):160-8.

29.

The role of CD40-CD154 interaction in antiviral T cell-independent IgG responses.

Szomolanyi-Tsuda E, Brien JD, Dorgan JE, Welsh RM, Garcea RL.

J Immunol. 2000 Jun 1;164(11):5877-82.

30.

T-cell-independent antiviral antibody responses.

Szomolanyi-Tsuda E, Welsh RM.

Curr Opin Immunol. 1998 Aug;10(4):431-5. Review.

PMID:
9722919
32.

Control of infections by NK cells.

Tay CH, Szomolanyi-Tsuda E, Welsh RM.

Curr Top Microbiol Immunol. 1998;230:193-220. Review. No abstract available.

PMID:
9586357
33.
34.

Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice.

Szomolanyi-Tsuda E, Dundon PL, Joris I, Shultz LD, Woda BA, Welsh RM.

Am J Pathol. 1994 Feb;144(2):359-71.

Supplemental Content

Loading ...
Support Center